Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cormedix Inc (CRMD)

Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 947,044
  • Shares Outstanding, K 78,789
  • Annual Sales, $ 43,470 K
  • Annual Income, $ -17,930 K
  • EBIT $ 104 M
  • EBITDA $ 104 M
  • 60-Month Beta 1.32
  • Price/Sales 21.79
  • Price/Cash Flow N/A
  • Price/Book 2.52

Options Overview Details

View History
  • Implied Volatility 79.20% (+2.52%)
  • Historical Volatility 52.17%
  • IV Percentile 53%
  • IV Rank 29.67%
  • IV High 165.02% on 04/04/25
  • IV Low 42.99% on 08/15/25
  • Expected Move (DTE 25) 1.80 (14.54%)
  • Put/Call Vol Ratio 0.41
  • Today's Volume 5,502
  • Volume Avg (30-Day) 2,493
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 44,841
  • Open Int (30-Day) 56,317
  • Expected Range 10.59 to 14.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.89
  • Number of Estimates 3
  • High Estimate 0.94
  • Low Estimate 0.81
  • Prior Year 0.22
  • Growth Rate Est. (year over year) +304.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.20 +34.67%
on 11/25/25
12.51 -0.92%
on 12/22/25
+2.71 (+28.00%)
since 11/21/25
3-Month
9.20 +34.67%
on 11/25/25
12.89 -3.88%
on 11/12/25
+1.12 (+9.94%)
since 09/22/25
52-Week
5.60 +121.25%
on 04/07/25
17.43 -28.92%
on 06/23/25
+3.82 (+44.57%)
since 12/20/24

Most Recent Stories

More News
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath

BERKELEY HEIGHTS, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening...

CRMD : 12.39 (+3.08%)
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Closed $17 million first tranche financing led by a strategic investment from CorMedix, Inc.

TLPH : 1.0700 (-2.73%)
CRMD : 12.39 (+3.08%)
CorMedix: Q3 Earnings Snapshot

CorMedix: Q3 Earnings Snapshot

CRMD : 12.39 (+3.08%)
CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance

‒ Q3 2025 Net Revenue of $104.3 million; Pro Forma Net Revenue of $130.8 million ‒ ‒ Q3 2025 Net Income of $108.6 million; Adjusted EBITDA of $71.9 million ‒ ‒ FY 2025 Pro Forma...

CRMD : 12.39 (+3.08%)
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025

BERKELEY HEIGHTS, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening...

CRMD : 12.39 (+3.08%)
Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

CRMD : 12.39 (+3.08%)
Talphera Announces the Appointment of Joe Todisco to Board of Directors

SAN MATEO, Calif. , Oct. 21, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), (Talphera), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies...

TLPH : 1.0700 (-2.73%)
CRMD : 12.39 (+3.08%)
CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

‒ Q3 2025 Unaudited Pro Forma Net Revenue of more than $125 million ‒ ‒ Q3 2025 Unaudited DefenCath Net Revenue of more than $85 million ‒ ‒ Raising FY 2025 Pro Forma Net Revenue Guidance...

CRMD : 12.39 (+3.08%)
RBC Capital Keeps Their Buy Rating on Cormedix (CRMD)

In a report released on October 8, Leonid Timashev from RBC Capital maintained a Buy rating on Cormedix. The company’s shares closed yesterday at $11.00.Elevate Your Investing Strategy: Take advantage...

CRMD : 12.39 (+3.08%)
CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allogeneic Blood and Marrow Transplant - - Topline Results from ReSPECT Study...

CRMD : 12.39 (+3.08%)

Business Summary

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed...

See More

Key Turning Points

3rd Resistance Point 13.33
2nd Resistance Point 12.92
1st Resistance Point 12.65
Last Price 12.39
1st Support Level 11.98
2nd Support Level 11.57
3rd Support Level 11.30

See More

52-Week High 17.43
Fibonacci 61.8% 12.91
Last Price 12.39
Fibonacci 50% 11.52
Fibonacci 38.2% 10.12
52-Week Low 5.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar